Filing exhibits
- 8-K Current report
- 10.1 Form of 1.5% Short Term Promissory Notes Dated February 10, 2022
- 10.2 Form of 3% Short Term Convertible Notes Dated February 10, 2022
- 10.3 6% Convertible Redeemable Note Dated September 29, 2021, Made by and Between AXIM Biotechnologies, Inc. and GS Capital Partners, LLC, As Amended
- Download Excel data file
- View Excel data file
Table of Contents